Follicular Lymphoma
📧 Sign up to get email alerts when something new happens for Follicular Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of SB-715992 in patients with metastatic or unresectable solid tumors and various Hodgkin's and non-Hodgkin's lymphomas has be…
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: Bryostatin and Vincristine in B-Cell Malignancies [Phase 1]
Phase 1 trial evaluating Bryostatin-1 in combination with Vincristine in several recurrent or refractory B-cell malignancies; the study has …
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluating Bryostatin-1 in combination with vincristine for progressive or relapsed non-Hodgkin lymphoma after bone…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating the combination of gossypol, paclitaxel, and carboplatin in patients with metastatic or unresectable solid tumors, …
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function [Phase 1]
Phase 1 trial of sorafenib in patients with metastatic or unresectable solid tumors, multiple myeloma, or non-Hodgkin lymphomas; the study h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Rituximab and Oblimersen in Treating Patients With Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating rituximab in combination with oblimersen for follicular lymphoma across stages II–IV has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating thalidomide in relapsed or refractory non-Hodgkin lymphoma has completed enrollment. The study included patients wi…
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
This clinical trial evaluated non-myeloablative allogeneic stem cell transplantation with matched unrelated donors across several hematologi…
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab [Phase 2]
Phase 2 study comparing Velcade (bortezomib) with fludarabine versus rituximab with fludarabine in follicular lymphoma patients previously t…
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma [Phase 1, Phase 2]
This clinical trial update reports on MDX-010 (ipilimumab) in treating recurrent or refractory lymphoma across multiple subtypes, with the s…
-
CLINICAL_TRIALS trial_result · 2012-09-17Clinical Trial Update: Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) [Phase 2, Phase 3]
Clinical trial evaluating autologous or donor stem cell transplantation for recurrent follicular lymphoma (grades 1-3); study terminated wit…
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: 131I-rituximab for Relapsed or Refractory Follicular or Mantle Cell Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating 131I-rituximab for relapsed or refractory follicular lymphoma or mantle cell lymphoma is reported; curre…
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial investigated chemotherapy with interferon alfa, with or without radiation therapy and peripheral stem cell transplantation, fo…
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: A Study of Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-cell or Follicular Non-Hodgkin's Lymphoma (RATE) [Phase 3]
Phase 3 study evaluating alternative dosing rate of rituximab in previously untreated diffuse large B-cell lymphoma and follicular lymphoma;…
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and Bexxar [Phase 2]
Phase 2 study evaluating radiation therapy plus Bexxar (tositumomab) for relapsed follicular non-Hodgkin's lymphoma; the trial was terminate…
-
CLINICAL_TRIALS trial_result · 2012-02-03Clinical Trial Update: Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma [Phase 3]
Phase 3 trial evaluating BiovaxID, a tumor-derived idiotype vaccine, in follicular lymphoma is ongoing with the trial status listed as unkno…
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: HuMax-CD20 i(Ofatumumab) n Follicular Lymphoma (FL) Patients Refractory to Rituximab [Phase 2]
Phase 2 trial results for HuMax-CD20 (ofatumumab) in rituximab-refractory follicular lymphoma are reported. The study has completed and resu…
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma [Phase 2]
Phase 2 clinical trial evaluating tipifarnib in relapsed or refractory lymphoma has completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-10-07Clinical Trial Update: A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas [Phase 1, Phase 2]
A clinical trial update reports the Phase 1/2 study of dulanermin in combination with rituximab for follicular and other low-grade CD20+ non…
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: Idiotypic Vaccination for Follicular Lymphoma Patients [Phase 2]
This Phase 2 clinical trial is evaluating an idiotypic vaccination strategy for patients with Follicular Lymphoma in first relapse or progre…
-
CLINICAL_TRIALS trial_result · 2011-08-26Clinical Trial Update: Ofatumumab (Humax-CD20) With CHOP (Cyclophosphamide,Doxorubicin, Vincristine, Predisolone) in Follicular Lymphoma (FL) Patients [Phase 2]
Phase 2 trial evaluating ofatumumab in combination with CHOP chemotherapy in follicular lymphoma completed; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies [Phase 2]
Phase II study assessing AT-101 as a single-agent therapy in relapsed or refractory B-cell malignancies has completed, reporting safety and …
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: A Phase II Study of VELCADE (Bortezomib) in Combination With Bendamustine and Rituximab in Subjects With Relapsed or Refractory Follicular Lymphoma [Phase 2]
This Phase II clinical trial evaluated Velcade (bortezomib) in combination with bendamustine and rituximab for relapsed or refractory follic…
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 study evaluating oblimersen sodium in combination with rituximab for recurrent B-cell non-Hodgkin lymphoma completed, with results…
-
CLINICAL_TRIALS trial_result · 2011-01-07Clinical Trial Update: Mechanism of Action of Galiximab in Subjects With Previously Untreated Follicular Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study evaluating the mechanism of action of galiximab in previously untreated follicular non-Hodgkin's lymphoma; the trial status is…